Two Sigma Investments, LP Onconova Therapeutics, Inc. Transaction History
Two Sigma Investments, LP
- $40.3 Billion
- Q1 2024
A detailed history of Two Sigma Investments, LP transactions in Onconova Therapeutics, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 37,987 shares of ONTX stock, worth $22,412. This represents 0.0% of its overall portfolio holdings.
Number of Shares
37,987
Previous 39,395
3.57%
Holding current value
$22,412
Previous $29,000
31.03%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding ONTX
# of Institutions
27Shares Held
1.71MCall Options Held
2.6KPut Options Held
0-
Vanguard Group Inc Valley Forge, PA709KShares$418,0840.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny268KShares$158,2340.0% of portfolio
-
Black Rock Inc. New York, NY249KShares$146,8380.0% of portfolio
-
Geode Capital Management, LLC Boston, MA193KShares$113,7860.0% of portfolio
-
David A. Siegel Two Sigma Advisers, LP | New York, Ny73.1KShares$43,1080.0% of portfolio
About Onconova Therapeutics, Inc.
- Ticker ONTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,895,600
- Market Cap $12.3M
- Description
- Onconova Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel products to treat cancer. It has two clinical-stage programs, including narazaciclib (ON 123300), a multi-targeted kinase inhibitor that is in Phase I study for solid tumors, as well as hematological malignancies as a single agent...